Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Hodgkin's Lymphoma T Cell Protocol
NCT00003423Phase 3Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- May 1995
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of asparaginase escherichia coli, cyclophosphamide, cytarabine, daunorubicin, dexamethasone in non-Hodgkin lymphoma (NHL), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
asparaginase escherichia colicyclophosphamidecytarabinedaunorubicindexamethasone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003423.